Adult Dosing

Infections, bacterial

• 250-500 mg PO tid
• Alt: 375 -500 Extended Release TABS PO bid
• Max: 2 g/day
• Use for 7-10 days

• ER form to be taken with food
• Do not cut/crush/chew ER form

Pediatric Dosing

Infections, bacterial

>1 month

• Immediate release
• 20-40 mg/kg/day PO divided Q8-12H
• Max: 1 g/day

[Outline]

• Adult Dosing
• Pediatric Dosing

• Treatment of the following bacterial infections caused by susceptible microorganisms
• Respiratory tract infections
• Otitis media
• Skin and skin structure infections
• Urinary tract infections

• Hypersensitivity to cephalosporins

• N/A

Renal Dose Adjustment

• Renal impairment: No dose adjustments

Hepatic Dose Adjustment

• Hepatic impairment: No adjustments defined

• Serious hypersensitivity reactions have been reported with the use of cefaclor. Epinephrine and other emergency measures must be available for management of acute reactions. Administer drug with caution to penicillin-sensitive patients because of possible cross-reactivity
• Clostridium difficile associated diarrhea which may vary in severity from mild to fatal colitis, has been reported with use of cefaclor
• Obtain culture and sensitivity tests before prescribing cefaclor. Prescribing cefaclor in the absence of a proven or strongly suspected bacterial infection increases the risk of the development of drug-resistant bacteria
• Prolonged use may result in the overgrowth of nonsusceptible organisms

Cautions: Use cautiously in

• Renal impairment
• Hx of GI disease
• Hx of antibiotic associated colitis
• Concurrent nephrotoxic agents
• Seizure disorder

Pregnancy Category:B

Breastfeeding: Limited information indicates that maternal cefaclor produce low levels in milk that are not expected to cause adverse effects in breastfed infants. This drug is compatible and considered safe with breastfeeding based upon data from LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 12 May 2010). Manufacturer advises caution.

• CNS: Seizures, agitation, nervousness, insomnia, confusion, hypertonia,dizziness, hallucinations, and somnolence
• GI: pseudomembranous colitis, diarrhea , nausea, vomiting, elevated LFTs, transient hepatitis, cholestatic jaundice
• Derm: Rashes, urticaria, pruritus, exfoliative dermatitis
• GU: Nephrotoxicity, vaginitis
• HEMA: Agranulocytosis, eosinophilia, neutropenia, thrombocytopenia, hemolytic anemia
• MISC: Allergic reactions including Stevens-Johnson syndrome, erythema multiforme and toxic epidermal necrolysis; serum sickness–like reactions, anaphylaxis, superinfection

• Bactericidal; binds to bacterial cell wall membrane; inhibits cell wall mucopeptide synthesis
• Not metabolized; CYP450: unknown
• Primarily excreted: (60-80% unchanged)
• Half-life: 1 hr (2.3-2.8 hrs in ESRD)

US Trade Name(s)

• Raniclor (Discontinued)

US Availability

cefaclor (generic)

• CAPS: 250, 500 mg
• Extended Release TABS: 375, 500 mg
• SUSP: 125 mg/5 mL
• SUSP: 187 mg/5 mL
• SUSP: 250 mg/5 mL
• SUSP: 375 mg/5 mL

Raniclor

• CHEW TABS: 125, 187, 250, 375 mg

Canadian Trade Name(s)

• Ceclor

Canadian Availability

cefaclor (generic)

• CAPS: 250, 500 mg
• SUSP: 125 mg/5 mL
• SUSP: 250 mg/5 mL
• SUSP: 375 mg/5 mL

Ceclor

• CAPS: 250, 500 mg
• SUSP: 125 mg/5 mL
• SUSP: 250 mg/5 mL
• SUSP: 375 mg/5 mL

UK Trade Name(s)

• Distaclor
• Distaclor MR

UK Availability

cefaclor (generic)

• CAPS: 250, 500 mg
• SUSP: 125 mg/5 mL (100 mL)
• SUSP: 250 mg/5 mL (100 mL)

Distaclor

• CAPS: 500 mg
• SUSP: 125 mg/5 mL (100 mL)
• SUSP: 250 mg/5 mL (100 mL)

Distaclor MR

• ETABS: 375 mg

Australian Trade Name(s)

• Aclor
• Ceclor
• Ceclor CD

Australian Availability

cefaclor (generic)

• ETABS: 375 mg
• SUSP: 125 mg/5 mL (100 mL)
• SUSP: 250 mg/5 mL (75 mL)

Aclor, Ceclor

• SUSP: 125 mg/5 mL (100 mL)
• SUSP: 250 mg/5 mL (75 mL)

Ceclor CD

• ETABS: 375 mg

[Outline]

Antimicrobials

Antibiotics

Cephalosporins; Second Generation

Infectious Disease

Antibiotics

Cephalosporins; Second Generation

Pricing data from www.DrugStore.com in U.S.A.

• Cefaclor 125 MG/5ML SUSR [Bottle] (RANBAXY PHARMACEUTICALS)
  75 5ml = $16.99
  225 5ml = $34.97
• Cefaclor 125 MG/5ML SUSR [Bottle] (RANBAXY PHARMACEUTICALS)
  150 5ml = $24.99
  450 5ml = $53.98
• Cefaclor 250 MG CAPS [Bottle] (WEST-WARD)
  30 mg = $60.99
  90 mg = $165.97
• Cefaclor 375 MG/5ML SUSR [Bottle] (RANBAXY PHARMACEUTICALS)
  100 5ml = $34.99
  300 5ml = $84.97
• Cefaclor 500 MG CAPS [Bottle] (WEST-WARD)
  30 mg = $87.99
  90 mg = $249.98
• Cefaclor 250 MG/5ML SUSR [Bottle] (RANBAXY PHARMACEUTICALS)
  150 5ml = $34.99
  450 5ml = $84.97
• Cefaclor 250 MG/5ML SUSR [Bottle] (RANBAXY PHARMACEUTICALS)
  75 5ml = $22.99
  225 5ml = $47.98

Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.

• Cefaclor 250 MG Oral Capsule (Alvogen, Inc.)
• Cefaclor 250 MG Oral Capsule (Ranbaxy Pharmaceuticals Inc.)
• Cefaclor 250 MG Oral Capsule (West-ward Pharmaceutical Corp)
• Cefaclor 250 MG Oral Capsule (bryant ranch prepack)
• Cefaclor 500 MG 12 HR Extended Release Tablet (Par Pharmaceutical Inc.)
• Cefaclor 500 MG 12 HR Extended Release Tablet (TEVA Pharmaceuticals USA Inc)
• Cefaclor 500 MG Oral Capsule (Alvogen, Inc.)
• Cefaclor 500 MG Oral Capsule (Ranbaxy Pharmaceuticals Inc.)
• Cefaclor 500 MG Oral Capsule (West-ward Pharmaceutical Corp)